MedPath

Clonidine-Remifentanil. Effect of the Combination on Acute Pain and Respiration in Healthy Volunteers

Phase 1
Completed
Conditions
Acute Pain
Respiration
Sedation
Interventions
Drug: Remifentanil+clonidine
Registration Number
NCT00730054
Lead Sponsor
Oslo University Hospital
Brief Summary

The hypothesis is that systemic remifentanil and Clonidine act in a synergistic manner to relief acute main in an experimental human pain model. Of interest is also the effect of the combination on respiration, sedation and cognitive behavior.

Detailed Description

To examine the possible synergistic effects og systemic remifentanil and clonidine. Its effects on respiration, cognitive function and sedation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Healthy volunteers
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1Remifentanil+clonidineClonidine
2Remifentanil+clonidineRemifentanil
4Remifentanil+clonidineRemifentanil+clonidine
3Remifentanil+clonidinePlacebo
Primary Outcome Measures
NameTimeMethod
Relief of pain(VAS reduction)Experimental
Secondary Outcome Measures
NameTimeMethod
Reduction in Minute ventilationExperimental
Reduction in CO2 stimulated Minute Ventilationexperimental
Reduction in BIS scoreExperimental
Performance on Stroop testExperimental

Trial Locations

Locations (1)

Dep of Anesthesia and Intensive Care, Rikshospitalet-Radiumhospitalet Medical Center

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath